INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | -64.7% | 11,859 | -54.9% | 0.00% | – |
| Q1 2020 | $17,000 | -99.7% | 26,307 | -99.4% | 0.00% | -100.0% |
| Q4 2019 | $5,507,000 | +102.2% | 4,444,000 | +7.4% | 0.02% | +100.0% |
| Q3 2019 | $2,724,000 | – | 4,139,000 | -52.0% | 0.01% | – |
| Q2 2019 | $0 | – | 8,628,000 | +5576.3% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 152,000 | -96.9% | 0.00% | -100.0% |
| Q4 2016 | $4,363,000 | +7691.1% | 4,895,000 | +9690.0% | 0.01% | – |
| Q3 2016 | $56,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 57,420,000 | $44,527,000 | 5.17% |
| Birch Grove Capital LP | 10,003,000 | $7,934,000 | 4.14% |
| PenderFund Capital Management Ltd. | 9,605,000 | $9,491,000 | 2.41% |
| Context Capital Management, LLC | 9,887,000 | $7,671,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $45,738,000 | 0.90% |
| DeepCurrents Investment Group LLC | 35,892,000 | $27,953,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,977,000 | $18,267,000 | 0.70% |
| WHITEBOX ADVISORS LLC | 23,150,000 | $17,847,000 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,397,000 | $21,720,000 | 0.46% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,435,000 | $15,079,000 | 0.26% |